Drug Treated Schizophrenia, Schizoaffective and Bipolar Disorder Patients Evaluated by qEEG Absolute Spectral Power and Mean Frequency Analysis

키워드

참고문헌 (37)

1. Niedermeyer E, "Electroencephalography:basic principles, clinical applications, and related fields", pp.235~251 (1993), Williams & Wilkins
2. Stevens JR, "Telemetered EEG-EOG during psychotic behaviors of schizophrenia", Arch Gen Psychiatry, 36, pp.251~262 (1979)
3. Bridgers SL., "Epileptiform abnormalities discovered on electroencephalographic screening of psychiatric inpatients", Arch Neurol, 44, pp.312~316
4. Small JG, "Clinical and quantitative EEG studies of mania", J Affect Disord, 53, pp.217~224 (1999)
5. Nunez PL, "Neocortical dynamics and human EEG rhythms", pp.123~145 (1995), Oxford University Press
6. John ER, "Quantitative electrophysiological characteristics and subtyping of schizophrenia", Biol Psychiatry, 36, pp.801~826 (1994)
7. Galderisi S, "Evidence-based medicine and electrophysiology in schizophrenia", Clin EEG Neurosci, 40, pp.62~77 (2009)
8. Begić D, "Quantitative EEG in ‘positive' and ‘negative' schizophrenia", Acta Psychiatr Scand, 101, pp.307~311 (2000)
9. Small JG, "Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia", Clin Electroencephalogr, 18, pp.124~135 (1987)
10. Hunter AM, "Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression", Am J Psychiatry, 163, pp.1426~1432 (2006)
11. van der Stelt O, "Application of electroencephalography to the study of cognitive and brain functions in schizophrenia", Schizophr Bull, 33, pp.955~970 (2007)
12. Kikuchi M, "Individual analysis of EEG band power and clinical drug response in schizophrenia", Neuropsychobiology, 51, pp.183~190 (2005)
13. Begić D, "Quantitative EEG in schizophrenic patients before and during pharmacotherapy", Neuropsychobiology, 41, pp.166~170 (2000)
14. Nagase Y, "Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment", Biol Psychiatry, 40, pp.452~456 (1996)
15. Kemali D, "Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment", Int J Psychophysiol, 13, pp.283~290 (1992)
16. Saletu B, "EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride", haloperidol, 1990, pp.1, 27~36
17. Miller A, "Regional patterns of brain activity in adults with a history of childhood-onset depression: gender differences and clinical variability", Am J Psychiatry, 159, pp.934~940 (2002)
18. Li Y, "Abnormal EEG complexity in patients with schizophrenia and depression", Clin Neurophysiol, 119, pp.1232~1241 (2008)
19. World Health Organization, "International Statistical Classification of Diseases and Related Health Problems (ICD) Volume 2, Instruction Manual" (2010), WHO
20. "QuikGrid 3-D rendering of a surface represented by scattered data points" (2009)[URL]
21. Boutros NN, "The status of spectral EEG abnormality as a diagnostic test for schizophrenia", Schizophr Res, 99, pp.225~237 (2008)
22. Centorrino F, "EEG abnormalities during treatment with typical and atypical antipsychotics", Am J Psychiatry, 159, pp.109~115 (2002)
23. Beasley CM Jr, "Safety of olanzapine", J Clin Psychiatry, 58(Suppl 10), pp.13~17 (1997)
24. Wyderski RJ, "Fatal status epilepticus associated with olanzapine therapy", Ann Pharmacother, 33, pp.787~789 (1999)
25. Guenther W, "Bilateral brain dysfunction during motor activation in type II schizophrenia measured by EEG mapping", Biol Psychiatry, 23, pp.295~311 (1988)
26. Itil TM, "EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra", Biol Psychiatry, 5, pp.1~13 (1972)
27. Joutsiniemi SL, "Marked clozapineinduced slowing of EEG background over frontal, central, and parietal scalp areas in schizophrenic patients", J Clin Neurophysiol, 18, pp.9~13 (2001)
28. Umbricht D, "Medical complications of new antipsychotic drugs", Schizophr Bull, 22, pp.475~483 (1996)
29. Czobor P, "Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients", J Clin Psychopharmacol, 13, pp.332~342 (1993)
30. 현준, "Effects of Psychotropic Drugs on Quantitative EEG among Patients with Schizophrenia-spectrum Disorders", Clinical Psychopharmacology and Neuroscience, 9(2), pp.78~85 (2011), 대한정신약물학회
31. Fink M., "EEG and behavior: Association or dissociation in man?", Integrative Psychiatry, 9, pp.108~113 (1993)
32. Baldessarini RJ., "Goodman & Gilman's the pharmacological basis of therapeutics", pp.447~483 (2001), McGraw-Hill
33. Yamadera H, "Pharmaco-EEG mapping of diazepam effects using different references and absolute and relative power", Pharmacopsychiatry, 26, pp.254~258 (1993)
34. McCarley RW, "Combining ERP and structural MRI information in first episode schizophrenia and bipolar disorder", Clin EEG Neurosci, 39, pp.57~60 (2008)
35. Sponheim SR, "Clinical and biological concomitants of resting state EEG power abnormalities in schizophrenia", Biol Psychiatry, 48, pp.1088~1097 (2000)
36. Knyazeva MG, "Alpha rhythm and hypofrontality in schizophrenia", Acta Psychiatr Scand, 118, pp.188~199 (2008)
37. Vuga M, "Long-term stability of frontal electroencephalographic asymmetry in adults with a history of depression and controls", Int J Psychophysiol, 59, pp.107~115 (2006)

관련 논문AI추천